Last reviewed · How we verify
peroperative infiltration of local anesthetics
peroperative infiltration of local anesthetics is a Small molecule drug developed by Hospices Civils de Lyon. It is currently in Phase 3 development.
At a glance
| Generic name | peroperative infiltration of local anesthetics |
|---|---|
| Sponsor | Hospices Civils de Lyon |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Analgesic Effect of Peripheral Dexmedetomidine (PHASE3)
- Intra-Peritoneal Local Anaesthesia After Cytoreductive Surgery (PHASE3)
- Local Analgesia Versus Local Peroperative Infiltration After Total Hip Replacement (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- peroperative infiltration of local anesthetics CI brief — competitive landscape report
- peroperative infiltration of local anesthetics updates RSS · CI watch RSS
- Hospices Civils de Lyon portfolio CI
Frequently asked questions about peroperative infiltration of local anesthetics
What is peroperative infiltration of local anesthetics?
peroperative infiltration of local anesthetics is a Small molecule drug developed by Hospices Civils de Lyon.
Who makes peroperative infiltration of local anesthetics?
peroperative infiltration of local anesthetics is developed by Hospices Civils de Lyon (see full Hospices Civils de Lyon pipeline at /company/hospices-civils-de-lyon).
What development phase is peroperative infiltration of local anesthetics in?
peroperative infiltration of local anesthetics is in Phase 3.